AI assistant
HERBALIFE LTD. — Director's Dealing 2024
Mar 27, 2024
32337_dirs_2024-03-27_506620a7-a906-4f97-a134-f7c7623ddce9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2024-03-17
Reporting Person: DeSimone John (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 281544 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Appreciation Rights | $31.255 | 2026-05-09 | Common Stock (116560) | Direct | |
| Stock Appreciation Rights | $28.595 | 2027-02-27 | Common Stock (122528) | Direct | |
| Stock Appreciation Rights | $20.17 | 2033-02-16 | Common Stock (216847) | Direct |
Footnotes
F1: Balance includes 75,154 unvested restricted stock units ("RSUs") previously granted to the Reporting Person, of which: 9,214 will vest on February 25, 2025, 32,969 will vest on February 16, 2025, and 32,971 will vest on February 16, 2026. All RSU vestings are subject to continued service through each applicable date.
F2: These stock appreciation rights were fully vested as of May 9, 2019.
F3: These stock appreciation rights were fully vested as of February 27, 2020.
F4: On February 16, 2023, the reporting person was granted 216,847 stock appreciation rights of which 1/3 has vested, and 1/3 will vest on February 16, 2025, and February 16, 2026.